MSB 2.10% $1.17 mesoblast limited

Cell Therapy News/Articles, page-17047

  1. 4,638 Posts.
    lightbulb Created with Sketch. 166
    what stop the profits of chemical therapy.
    now there is the reason big pharma hasnt taken over stem cell companies and quickly promoted thier experiments to save people.

    any cancer nurse will tell you that chemotherapy is very expensive. and often doesnt save the patient. never providing you g stem cell to strengthen the immune system..In fact destroys most of the immune sys. along with cancer cells, so that the patient has no effective resistence against other attackers, which require more drugs ( and more money for big pharma and medical industry)
    but it will come , eventually
    Last edited by rae915: 22/10/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.